Sign In
Buy STML
$11.83
+0 (+0%)
At Close: Sep 04, 2020
Context Therapeutics says clinical partner Stemline Therapeutics receives FDA approval for ORSERDU to treat certain breast cancers
08:33am, Tuesday, 31'st Jan 2023
Context Therapeutics (NASDAQ:CNTX) has announced that its clinical trial collaborator, Stemline Therapeutics Inc, a wholly-owned subsidiary of The Menarini Group, has received approval from the US Fo
